Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-20-005187

Options or other derivatives

  • Chief Commercial Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Maloberti Renaud Bertrand Chief Commercial Officer 2020-01-25 Grant or award · Stock Options +20,000 20,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…